Home
/
Conditions
/ Depression: The Biological Drivers
Neurological Health
Schedule a Consultation
Depression: The Biological Drivers
Depression is not a serotonin deficiency. It is a downstream expression of upstream physiological disruption including neuroinflammation, HPA axis dysregulation, thyroid dysfunction, gut-brain axis impairment, hormonal decline, and metabolic dysfunction. The conventional model treats depression as a neurotransmitter imbalance correctable with SSRIs, while functional medicine identifies and resolves the biological drivers that produce the mood and cognitive disruption patients experience. At The Lamkin Clinic, we evaluate the physiology behind the symptom.
Neurological HealthRoot Cause MedicinePhysiologically Treatable
~30%of depression patients do not respond adequately to first-line SSRI treatment
50%+of treatment-resistant depression has an identifiable metabolic or hormonal driver
Addressablewhen the biological mechanism is identified and treated directly
← Back to Conditions
Condition: Depression: The Biological Drivers | Category: Neurological Health | Reviewed by: Brian Lamkin, DO
What Is Depression Biology?
Depression, as understood through a functional medicine framework, is not a disease defined by low serotonin. It is a clinical syndrome produced by the convergence of multiple upstream biological disruptions that alter neurotransmitter synthesis, neuronal signaling, energy metabolism, and neuroplasticity in the central nervous system. The DSM criteria describe the symptoms; they do not explain the mechanism.
The biological drivers most consistently identified in depressed patients include neuroinflammation (elevated pro-inflammatory cytokines crossing the blood-brain barrier), HPA axis dysregulation (abnormal cortisol patterns that impair hippocampal neurogenesis), thyroid dysfunction (insufficient T3 for serotonin and dopamine synthesis), gut-brain axis impairment (reduced tryptophan availability from dysbiotic microbiomes), hormonal decline (testosterone, DHEA-S, and estradiol depletion affecting mood-regulating pathways), and metabolic dysfunction (insulin resistance impairing cerebral glucose utilization). The conventional model treats one downstream consequence; the functional model identifies and addresses the upstream drivers.
Key principle: When a patient does not respond to an SSRI, the most common explanation is not that they need a different SSRI. It is that the biological driver producing the neurotransmitter disruption has never been identified or treated. Inflammation, cortisol, thyroid, gut, and hormone status are rarely evaluated in psychiatric care.
Why It Matters
Clinical Consequences
- Depression is the leading cause of disability worldwide and produces measurable cognitive, metabolic, cardiovascular, and immunological consequences beyond mood
- Treatment-resistant depression affects approximately 30% of patients and is associated with progressive hippocampal atrophy, accelerated cognitive decline, and elevated cardiovascular mortality
- The biological drivers of depression compound over time: untreated neuroinflammation, cortisol dysregulation, and hormonal decline do not self-correct and produce progressive neurological deterioration
- Suicide risk correlates with inflammatory burden and HPA axis dysfunction, not solely with symptom severity as measured by standard depression scales
Why Standard Treatment Falls Short
- SSRIs modulate serotonin reuptake without addressing the inflammatory, hormonal, thyroid, or metabolic drivers that reduced serotonin production and signaling in the first place
- Psychiatric evaluation does not include laboratory testing for cortisol, thyroid function, inflammatory markers, vitamin D, or hormonal status in standard practice
- Medication augmentation strategies add second and third psychiatric medications rather than investigating the biological mechanism producing treatment resistance
- The gut-brain axis is not assessed despite approximately 95% of serotonin being produced in the gastrointestinal tract by enterochromaffin cells dependent on tryptophan and a healthy microbiome
Common Symptoms
Mood and Motivation
- Persistent low mood that does not lift with positive circumstances
- Anhedonia: loss of interest or pleasure in previously enjoyed activities
- Emotional flatness or numbness rather than acute sadness
- Irritability and low frustration tolerance disproportionate to triggers
Energy and Cognition
- Fatigue and low motivation that do not resolve with rest
- Cognitive slowing, poor concentration, and impaired decision-making
- Memory impairment, particularly short-term and working memory
- Mental fog that worsens throughout the day
Physical and Behavioral
- Sleep disruption: insomnia, early waking, or hypersomnia
- Appetite changes with unexplained weight gain or loss
- Psychomotor retardation or agitation
- Social withdrawal and reduced capacity for interpersonal engagement
Root Causes: A Functional Medicine Perspective
The functional medicine approach to depression does not reject psychiatric medication. It asks why the brain's neurotransmitter systems are disrupted in the first place, and whether addressing the upstream driver can resolve or reduce the depressive symptoms more effectively than medication alone.
Neuroinflammation
Elevated inflammatory cytokines including IL-6, TNF-alpha, and IL-1 beta cross the blood-brain barrier and activate microglial cells, which shift tryptophan metabolism away from serotonin production toward the kynurenine pathway, producing neurotoxic metabolites (quinolinic acid) that impair neuroplasticity and hippocampal function. Elevated hs-CRP in depressed patients is one of the strongest predictors of SSRI non-response.
HPA Axis Dysregulation
Chronic cortisol elevation from HPA axis dysregulation directly impairs hippocampal neurogenesis, the process by which new neurons are formed in the brain region most critical for mood regulation and memory. Flat or inverted diurnal cortisol patterns are associated with treatment-resistant depression, and DHEA-S depletion (the neurosteroid that counterbalances cortisol in the brain) compounds the neurotoxic cortisol effect.
Thyroid Dysfunction
Thyroid hormone, specifically free T3, is a direct regulator of serotonin and dopamine receptor density in the brain. Subclinical hypothyroidism produces depressive symptoms that are indistinguishable from major depressive disorder on clinical assessment. Patients with depression and a TSH above 2.5 with low-normal free T3 frequently improve with thyroid optimization, often before or instead of psychiatric medication adjustment.
Gut-Brain Axis Impairment
The enteric nervous system produces approximately 95% of the body's serotonin. Gut dysbiosis reduces the availability of tryptophan (the essential amino acid precursor to serotonin), impairs short-chain fatty acid production that supports blood-brain barrier integrity, and promotes lipopolysaccharide translocation that drives systemic and neuroinflammation. Depression that coexists with GI symptoms is a strong indicator that the gut-brain axis is a primary driver.
Conventional vs Functional Medicine Approach
| Domain | Conventional Medicine | Functional Medicine |
|---|---|---|
| Assessment | Clinical interview and symptom questionnaires; rarely includes laboratory testing | Comprehensive biological evaluation: cortisol, thyroid panel, inflammatory markers, vitamin D, hormones, metabolic panel |
| Treatment | SSRIs as first line; augmentation with additional psychiatric medications for non-responders | Identifies and treats the specific biological driver: inflammation, cortisol, thyroid, gut, hormonal, or metabolic |
| Goal | Symptom reduction measured by PHQ-9 or similar scale | Resolution of the upstream mechanism producing the depressive phenotype |
| Testing | No standard laboratory workup for depression in psychiatric guidelines | Cortisol, DHEA-S, full thyroid panel, hs-CRP, vitamin D, B12, homocysteine, fasting insulin, sex hormones |
Key Labs to Evaluate
Depression with a biological driver produces a detectable laboratory signature. The following markers identify the most common upstream mechanisms.
CortisolHPA axis status. Elevated or flattened cortisol impairs hippocampal neurogenesis.
→DHEA-SNeurosteroid counterbalance to cortisol. Low DHEA-S amplifies cortisol neurotoxicity.
→Vitamin DNeuroactive hormone. Deficiency independently associated with depression severity.
→Free T3Active thyroid hormone regulating serotonin and dopamine receptor density in the brain.
→hs-CRPSystemic inflammatory burden. Elevated hs-CRP predicts SSRI non-response.
→How to Interpret These Labs Together
Elevated hs-CRP with flat or elevated cortisol and low DHEA-S is the inflammatory-HPA pattern most strongly associated with treatment-resistant depression. This patient has neuroinflammation compounded by cortisol neurotoxicity without adequate neurosteroid protection. SSRIs cannot resolve this mechanism because the problem is upstream of serotonin reuptake.
Low free T3 with TSH above 2.5 and low vitamin D identifies thyroid-mediated depression with a nutrient cofactor deficiency. Both impair neurotransmitter synthesis directly. Addressing thyroid and vitamin D frequently resolves depressive symptoms that years of SSRI treatment could not.
Elevated fasting insulin with low DHEA-S indicates metabolic-hormonal depression in which insulin resistance impairs cerebral glucose utilization while hormonal decline reduces neuroplasticity and mood-stabilizing neurosteroid tone.
Common Patterns Seen in Patients
- The patient on their third SSRI: PHQ-9 score persistently elevated despite adequate trials of sertraline, escitalopram, and duloxetine. hs-CRP 4.1, cortisol flat, DHEA-S depleted, vitamin D 22 ng/mL. The biological drivers were never assessed. Anti-inflammatory intervention, cortisol rhythm restoration, DHEA supplementation, and vitamin D repletion produced meaningful mood improvement within 6 weeks.
- Postpartum depression that persists beyond 12 months: Attributed to psychological adjustment. Thyroid panel revealed TPO antibodies elevated at 310 IU/mL with free T3 in the lower quartile. Postpartum thyroiditis producing autoimmune-driven hypothyroidism that directly impaired serotonin synthesis. Thyroid optimization resolved the depression.
- Depression with prominent GI symptoms: Chronic bloating, constipation, and food reactivity alongside persistent low mood and fatigue. Comprehensive stool analysis revealed significant dysbiosis with reduced Lactobacillus and Bifidobacterium species. Gut restoration improved both GI symptoms and mood concurrently.
- Midlife depression in men attributed to aging: Testosterone 285 ng/dL, DHEA-S depleted, cortisol elevated from occupational stress. Hormonal decline and HPA activation produced the depressive phenotype. Testosterone optimization and cortisol management restored mood and energy without psychiatric medication.
Treatment and Optimization Strategy
Biological Driver Identification
Treatment begins with identifying which upstream mechanism or combination of mechanisms is producing the depressive phenotype. The lab pattern determines the treatment strategy, not the symptom label.
Anti-Inflammatory and HPA Interventions
- Omega-3 fatty acids (3 to 4g EPA+DHA daily) with emphasis on EPA, which has the strongest evidence for depression-specific anti-inflammatory benefit
- Curcumin (1000mg daily as bioavailable form) reduces IL-6 and TNF-alpha; demonstrated efficacy comparable to fluoxetine in clinical trials
- Cortisol rhythm restoration through sleep optimization, morning light exposure, stress management, and adaptogenic support (ashwagandha, rhodiola)
- DHEA supplementation when DHEA-S is depleted, restoring the neurosteroid counterbalance to cortisol in the brain
Thyroid, Gut, and Hormone Optimization
- Thyroid optimization targeting free T3 in the upper half of the reference range; T3 supplementation when conversion is impaired
- Vitamin D repletion to 60 to 80 ng/mL with cofactors (K2, magnesium); vitamin D receptors are present throughout mood-regulating brain regions
- Gut microbiome restoration through prebiotic fiber, targeted probiotics, and elimination of gut-disrupting triggers to restore tryptophan availability
- Hormone optimization including testosterone, DHEA-S, and estradiol when deficiency contributes to the depressive mechanism
What Most Doctors Miss
- Depression is not evaluated biologically: standard psychiatric assessment includes no laboratory testing for the metabolic, inflammatory, hormonal, or thyroid drivers that produce the majority of treatment-resistant presentations
- SSRI non-response is treated with more SSRIs: augmentation strategies add psychiatric medications rather than asking why the first medication did not work; the answer is almost always an unaddressed biological driver
- The gut-brain axis is not assessed: approximately 95% of serotonin is produced in the gut, yet GI function, microbiome status, and tryptophan metabolism are never evaluated in depression treatment
- Subclinical thyroid dysfunction is dismissed: a TSH of 3.5 with low free T3 produces clinically significant depressive symptoms but is universally classified as normal by psychiatric and primary care providers
When to Seek Medical Care
If you experience persistent low mood, loss of interest, fatigue, cognitive impairment, or sleep disruption that has not responded to standard psychiatric treatment, a comprehensive biological evaluation is warranted. This is especially important if you have been on multiple medications without adequate response, or if your depression coexists with fatigue, thyroid symptoms, GI dysfunction, or hormonal changes.
At The Lamkin Clinic, depression evaluation includes cortisol, DHEA-S, a full thyroid panel, inflammatory markers, vitamin D, B vitamins, sex hormones, and metabolic markers reviewed together as an integrated biological picture.
Recommended Testing
Identifying the biological drivers of depression requires testing that standard psychiatric evaluation does not include. The following markers provide the most clinically actionable information.
Foundational Labs
- Cortisol (AM)
- DHEA-S
- TSH, Free T3, Free T4
- Vitamin D (25-OH)
Advanced Assessment
- hs-CRP
- Homocysteine
- Vitamin B12
- Fasting Insulin
- Testosterone (total and free)
Recommended Panel
Hormone Optimization PanelComprehensive evaluation including cortisol, DHEA-S, thyroid markers, sex hormones, vitamin D, and key metabolic indicators.
→Not sure which testing applies to you?
Explore All Testing Options →Frequently Asked Questions
Is depression really caused by a chemical imbalance?
The serotonin deficiency model has been largely discredited by recent research. Depression is better understood as a convergence of neuroinflammation, HPA axis dysregulation, hormonal decline, thyroid dysfunction, gut-brain axis impairment, and metabolic disruption. Multiple biological drivers produce the neurotransmitter changes that SSRIs attempt to correct downstream.
Why has my antidepressant stopped working?
Antidepressant tachyphylaxis occurs when the upstream biological drivers of depression remain unaddressed. The medication modulates neurotransmitter reuptake but does not resolve the inflammation, cortisol dysregulation, thyroid dysfunction, or hormonal decline that produced the disruption. When the biological load increases, the medication loses its compensatory capacity.
Can thyroid dysfunction cause depression?
Yes. Thyroid hormone is essential for serotonin and dopamine synthesis in the central nervous system. Even subclinical hypothyroidism with a TSH in the upper reference range can produce clinically significant depressive symptoms. Free T3 is the most relevant marker because it is the metabolically active thyroid hormone that directly influences neurotransmitter production.
What labs should be tested for depression?
A comprehensive biological evaluation for depression includes cortisol, DHEA-S, full thyroid panel (TSH, free T3, free T4, reverse T3, TPO antibodies), vitamin D, hs-CRP, fasting insulin, homocysteine, vitamin B12, and sex hormones. These markers identify the specific biological drivers that standard psychiatric evaluation does not assess.
Can gut health affect depression?
Yes. Approximately 90 to 95 percent of serotonin is produced in the gut by enterochromaffin cells, and production depends on tryptophan availability and a healthy microbiome. Gut dysbiosis, intestinal permeability, and chronic GI inflammation directly impair serotonin precursor production and activate systemic inflammatory pathways that worsen neuroinflammation and depressive symptoms.
How The Lamkin Clinic Approaches Depression
Clinical Perspective
The patients I see with treatment-resistant depression are not treatment-resistant. They are investigation-resistant. No one has tested their cortisol, their thyroid, their inflammatory markers, or their hormones. When I run those labs, the pattern is almost always there: elevated inflammation, flat cortisol, low T3, depleted DHEA-S, or some combination. Once we identify the mechanism, we can treat it directly. The depression frequently improves in ways that years of SSRI adjustments could not achieve.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
At The Lamkin Clinic, depression evaluation begins with comprehensive biological testing: cortisol, DHEA-S, full thyroid panel, hs-CRP, vitamin D, sex hormones, and metabolic markers. We identify the specific driver or combination of drivers producing the depressive phenotype and build treatment around the mechanism. This approach does not replace psychiatric care when indicated; it provides the biological foundation that psychiatric treatment alone does not address.
Related Conditions
Brain FogNeuroinflammation and impaired neurotransmitter signaling produce both depression and cognitive dysfunction
→Anxiety PhysiologyHPA axis dysregulation produces both anxiety and depressive phenotypes through shared cortisol pathways
→Cognitive DeclineChronic depression accelerates hippocampal atrophy and cognitive deterioration
→Chronic FatigueMitochondrial dysfunction and cortisol disruption underlie both fatigue and depressive phenotypes
→Thyroid DysfunctionSubclinical hypothyroidism is one of the most common unaddressed causes of depressive symptoms
→Gut DysbiosisGut-brain axis impairment reduces serotonin precursor availability and drives neuroinflammation
→Related Symptoms
FatigueCortisol dysregulation and mitochondrial impairment producing persistent low energy
→Brain FogNeuroinflammation and impaired neurotransmitter signaling reducing cognitive clarity
→Sleep DisturbanceHPA axis dysregulation disrupting circadian cortisol rhythm and sleep architecture
→Chronic StressSustained HPA activation producing the cortisol burden that drives depressive neurobiology
→Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Depression has identifiable biological drivers that laboratory testing can reveal.
The Lamkin Clinic evaluates the physiology behind depression with comprehensive cortisol, thyroid, inflammatory, and hormonal testing. Schedule a consultation for a root-cause biological evaluation.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.